Duodenal chromogranin a cell density as a biomarker for the diagnosis of irritable bowel syndrome

Gastroenterology Research and Practice

Volumn 2014, Issue , 2014, Pages

  El Salhy, Magdy ^a,b   Gilja, Odd Helge ^b,c   Gundersen, Doris ^d   Hatlebakk, Jan Gunnar ^b   Hausken, Trygve ^b,c  

^a Stord Hospital   (Norway)

^b UNIVERSITY OF BERGEN   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d Department of Research ^*  (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CHROMOGRANIN A; PEROXIDASE;

ADOLESCENT; ADULT; AGED; ARTICLE; CELL DENSITY; CONTROLLED STUDY; DISEASE MARKER; DUODENUM; DUODENUM BIOPSY; EPITHELIUM CELL; FEMALE; GASTROINTESTINAL SYMPTOM; GASTROINTESTINAL TRACT; GASTROSCOPY; HELICOBACTER PYLORI; HISTOPATHOLOGY; HUMAN; IMAGE ANALYSIS; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IRRITABLE COLON; KRUSKAL WALLIS TEST; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ROOM TEMPERATURE; SENSITIVITY AND SPECIFICITY; UNIVERSITY HOSPITAL;

EID: 84904134157     PISSN: 16876121     EISSN: 1687630X     Source Type: Journal    
DOI: 10.1155/2014/462856     Document Type: Article

References (37)

1. El-Salhy M., Gundersen D., Hatlebakk J. G., Hausken T., Irritable Bowel Syndrome: Diagnosis, Pathogenesis and Treatment Options 2012 New York, NY, USA Nova Science Publishers
2. Spiller R., Camilleri M., Longstreth G. F., Do the symptom-based, Rome criteria of irritable bowel syndrome lead to better diagnosis and treatment outcomes? Clinical Gastroenterology and Hepatology 2010 8 2 125 2-s2.0-75349088377 10.1016/j.cgh.2009.12.018
3. Quigley E. M., The "con" case. The Rome process and functional gastrointestinal disorders: the barbarians are at the gate! Neurogastroenterology and Motility 2007 19 10 793 797 2-s2.0-38449121572 10.1111/j.1365-2982.2007.01000.x
4. Jellema P., van der Windt D. A. W. M., Schellevis F. G., van der Horst H. E., Systematic review: accuracy of symptom-based criteria for diagnosis of irritable bowel syndrome in primary care. Alimentary Pharmacology and Therapeutics 2009 30 7 695 706 2-s2.0-69949129305 10.1111/j.1365-2036.2009. 04087.x
5. El-Salhy M., Irritable bowel syndrome: diagnosis and pathogenesis. World Journal of Gastroenterology 2012 18 37 5151 5163 2-s2.0-84867754193 10.3748/wjg.v18.i37.5151
6. Manning A. P., Thompson W. G., Heaton K. W., Morris A. F., Towards positive diagnosis of the irritable bowel. British Medical Journal 1978 2 6138 653 654 2-s2.0-0018174715 (Pubitemid 9004104)
7. Drossman D. A., Rome III: the new criteria. Chinese Journal of Digestive Diseases 2006 7 4 181 185 2-s2.0-34248187747 10.1111/j.1443-9573.2006.00265.x
8. Drossman D. A., The functional gastrointestinal disorders and the Rome II process. Gut 1999 45 supplement 2 1 5 2-s2.0-0032879485
9. Lin O. S., Colonoscopy in irritable bowel syndrome: whom are we reassuring? Gastrointestinal Endoscopy 2005 62 6 900 902 2-s2.0-27844459454 10.1016/j.gie.2005.08.036 (Pubitemid 41654426)
10. Kruis W., Thieme C., Weinzierl M., Schüssler P., Holl J., Paulus W., A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology 1984 87 1 1 7 2-s2.0-0021265175 (Pubitemid 14122746)
11. Bellentani S., Baldoni P., Petrella S., Tata C., Armocida C., Marchegiano P., Saccoccio G., Manenti F., Andreoli C., D'Autilia N., Daya G., De Gesu R., Feltri G., Linardelli D., Luppi G., Mazzi W., Padula M. S., Pieralisi F., Rossi L., A simple score for the identification of patients at high risk of organic diseases of the colon in the family doctor consulting room. Family Practice 1990 7 4 307 312 2-s2.0-0025601725
12. Mazumdar T. N., Prasad K. V., Bhat P. V., Formulation of a scoring chart for irritable bowel syndrome (IBS): a prospective study. Indian Journal of Gastroenterology 1988 7 2 101 102 2-s2.0-0023989015
13. Longstreth G. F., Thompson W. G., Chey W. D., Houghton L. A., Mearin F., Spiller R. C., Functional bowel disorders. Gastroenterology 2006 130 5 1480 1491 2-s2.0-33646201684 10.1053/j.gastro.2005.11.061
14. Gladman L. M., Gorard D. A., General practitioner and hospital specialist attitudes to functional gastrointestinal disorders. Alimentary Pharmacology and Therapeutics 2003 17 5 651 654 2-s2.0-0037359378 10.1046/j.1365-2036.2003. 01484.x (Pubitemid 36418888)
15. Barbara G., Stanghellini V., Biomarkers in IBS: when will they replace symptoms for diagnosis and management? Gut 2009 58 12 1571 1575 2-s2.0-72549116062 10.1136/gut.2008.169672
16. Barbara G., Cremon C., De Giorgio R., Dothel G., Zecchi L., Bellacosa L., Carini G., Stanghellini V., Corinaldesi R., Mechanisms underlying visceral hypersensitivity in irritable bowel syndrome. Current Gastroenterology Reports 2011 13 4 308 315 2-s2.0-80051592401 10.1007/s11894-011-0195-7
17. Ford A. C., Talley N. J., Schoenfeld P. S., Quigley E. M. M., Moayyedi P., Efficacy of antidepressants and psychological therapies in irritable bowel syndrome: systematic review and meta-analysis. Gut 2009 58 3 367 378 2-s2.0-61649089108 10.1136/gut.2008.163162
18. Spiller R. C., Potential biomarkers. Gastroenterology Clinics of North America 2011 40 1 121 139 2-s2.0-79951562115 10.1016/j.gtc.2011.01.001
19. Sandström O., El-Salhy M., Ageing and endocrine cells of human duodenum. Mechanisms of Ageing and Development 1999 108 1 39 48 2-s2.0-0033119598 10.1016/S0047-6374(98)00154-7 (Pubitemid 29210238)
20. El-Salhy M., Vaali K., Dizdar V., Hausken T., Abnormal small-intestinal endocrine cells in patients with irritable bowel syndrome. Digestive Diseases and Sciences 2010 55 12 3508 3513 2-s2.0-78649330100 10.1007/s10620-010-1169-6
21. Taupenot L., Harper K. L., O'Connor D. T., The chromogranin-secretogranin family. New England Journal of Medicine 2003 348 12 1134 1149 2-s2.0-0037456743 10.1056/NEJMra021405 (Pubitemid 36337325)
22. Wiedenmann B., Huttner W. B., Synaptophysin and chromogranins/ secretogranins-widespread constituents of distinct types of neuroendocrine vesicles and new tools in tumor diagnosis. Virchows Archiv B: Cell Pathology Including Molecular Pathology 1989 58 2 95 121 2-s2.0-0024347409 (Pubitemid 20012954)
23. Deftos L. J., Chromogranin A: its role in endocrine function and as an endocrine and neuroendocrine tumor marker. Endocrine Reviews 1991 12 2 181 187 2-s2.0-0025793164
24. El-Salhy M., Lomholt-Beck B., Hausken T., Chromogranin a as a possible tool in the diagnosis of irritable bowel syndrome. Scandinavian Journal of Gastroenterology 2010 45 12 1435 1439 2-s2.0-78649244540 10.3109/00365521.2010. 503965
25. Sjolund K., Sanden G., Hakanson R., Sundler F., Endocrine cells in human intestine: an immunocytochemical study. Gastroenterology 1983 85 5 1120 1130 2-s2.0-0020501561 (Pubitemid 13007805)
26. El-Salhy M., Gundersen D., Gilja O. H., Hatlebakk J. G., Hausken T., Is irritable bowel syndrome an organic disorder? World Journal of Gastroenterology 2014 20 2 384 400 10.3748/wjg.v20.i2.384
27. Lo W., Sano K., Lebwohl B., Diamond B., Green P. H. R., Changing presentation of adult celiac disease. Digestive Diseases and Sciences 2003 48 2 395 398 2-s2.0-0037329004 10.1023/A:1021956200382 (Pubitemid 36233010)
28. El-Salhy M., Lomholt-Beck B., Gundersen D., The prevalence of celiac disease in patients with irritable bowel syndrome. Molecular Medicine Reports 2011 4 3 403 405 2-s2.0-79953780024 10.3892/mmr.2011.466
29. van der Wouden E.-J., Nelis G. F., Vecht J., Screening for coeliac disease in patients fulfilling the Rome II criteria for irritable bowel syndrome in a secondary care hospital in the Netherlands: a prospective observational study. Gut 2007 56 3 444 445 2-s2.0-34047160885 10.1136/gut.2006.112052 (Pubitemid 46579784)
30. Locke G. R. III, Murray J. A., Zinsmeister A. R., Melton L. J. III, Talley N. J., Celiac disease serology in irritable bowel syndrome and dyspepsia: a population-based case-control study. Mayo Clinic Proceedings 2004 79 4 476 482 2-s2.0-1642546483 (Pubitemid 38401767)
31. Hin H., Bird G., Fisher P., Mahy N., Jewell D., Coeliac disease in primary care: case finding study. British Medical Journal 1999 318 7177 164 167 2-s2.0-0033573706 (Pubitemid 29192607)
32. Shahbazkhani B., Forootan M., Merat S., Akbari M. R., Nasserimoghadam S., Vahedi H., Malekzadeh R., Coeliac disease presenting with symptoms of irritable bowel syndrome. Alimentary Pharmacology and Therapeutics 2003 18 2 231 235 2-s2.0-0042128362 10.1046/j.1365-2036.2003.01666.x (Pubitemid 36951660)
33. Catassi C., Kryszak D., Louis-Jacques O., Duerksen D. R., Hill I., Crowe S. E., Brown A. R., Procaccini N. J., Wonderly B. A., Hartley P., Moreci J., Bennett N., Horvath K., Burk M., Fasano A., Detection of celiac disease in primary care: a multicenter case-finding study in North America. The American Journal of Gastroenterology 2007 102 7 1454 1460 2-s2.0-34250821914 10.1111/j.1572-0241.2007.01173.x (Pubitemid 46976276)
34. Korkut E., Bektas M., Oztas E., Kurt M., Cetinkaya H., Ozden A., The prevalence of celiac disease in patients fulfilling Rome III criteria for irritable bowel syndrome. European Journal of Internal Medicine 2010 21 5 389 392 2-s2.0-77956416465 10.1016/j.ejim.2010.06.004
35. Sanders D. S., Patel D., Stephenson T. J., Ward A. M., McCloskey E. V., Hadjivassiliou M., Lobo A. J., A primary care cross-sectional study of undiagnosed adult coeliac disease. European Journal of Gastroenterology and Hepatology 2003 15 4 407 413 2-s2.0-0242416630 10.1097/00042737-200304000-00012 (Pubitemid 36521040)
36. Verdu E. F., Armstrong D., Murray J. A., Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. The American Journal of Gastroenterology 2009 104 6 1587 1594 2-s2.0-67349226415 10.1038/ajg.2009.188
37. Wahnschaffe U., Schulzke J.-D., Zeitz M., Ullrich R., Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clinical Gastroenterology and Hepatology 2007 5 7 844 850 2-s2.0-34447099633 10.1016/j.cgh.2007.03.021 (Pubitemid 47031067)